Source: Pharmacy Times articles
These results suggest that individuals who are immunocompromised with type 2 diabetes (T2D) may need multiple doses of a pneumococcal conjugate vaccine (PCV) to sustain their protection.
Read More
by MM360 Staff | Apr 19, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
These results suggest that individuals who are immunocompromised with type 2 diabetes (T2D) may need multiple doses of a pneumococcal conjugate vaccine (PCV) to sustain their protection.
Read More